Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0217 has been discontinued.
View all Non-selective Ionotropic Glutamate products.D-Glutamic acid is an excitatory amino acid acting at NMDA receptors; less active than the L-isomer.
L-isomer also available.
M. Wt | 147.13 |
Formula | C5H9NO4 |
Storage | Store at RT |
CAS Number | 6893-26-1 |
PubChem ID | 23327 |
InChI Key | WHUUTDBJXJRKMK-GSVOUGTGSA-N |
Smiles | N[C@@]([H])([C@](O)=O)CCC(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Olverman et al (1988) Structure/activity relations of N-MthD.-aspartate receptor ligands as studied by their inhibition of [3H]-D-2-amino-5-phosphonopentanoic acid binding in rat brain membranes. Neuroscience 26 17 PMID: 2901691
Watkins (1986) Twenty five years of excitatory amino acid research. Excitatory Amino Acids. Eds. Roberts et al. Macmil p1-39
Keywords: D-Glutamic acid, D-Glutamic acid supplier, Endogenous, non-selective, agonists, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, Non-selective, mGlu, Amino, Acids, 0217, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for D-Glutamic acid.
There are currently no reviews for this product. Be the first to review D-Glutamic acid and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.